Operational Efficiencies Improve, Increasing EBITDA and Cash Flow
Revenue increased 3% to $5.6M compared to $5.5M in Q1 2025 and decreased 7% from $6.0M in Q2 2024
Adjusted EBITDA increased $308,000 to $836,000 compared to $528,000 in Q2 2024
The Company was cash flow positive for the quarter, with cash flow from operations increasing $325,000 from Q2 2024
Subscriptions increased to 971 at the end of Q2 2025 from 955 at the end of Q1 2025 and 867 in Q2 2024
Fiscal 2026 First Quarter Highlights
Operating income increased to $959,000, from an operating loss of $829,000.
Net income increased to $324,000 from a net loss of $1.4 million in the prior year quarter.
Gross profit increased 31.2 percent to $6.1 million, from $4.6 million in the prior year quarter.
Gross margin improved 410 basis points to 15.4 percent, from 11.3 percent in the prior year quarter.
Outlook
Revenue for the fiscal 2026 second quarter is expected to be approximately $40 million-$42 million.
Gross margin goal for fiscal 2026 second quarter is expected to be approximately 15-16 percent.
Record Quarterly Revenue of $6.3 Million in Q2; a 6-fold Increase YoY and 50% Growth QoQ
Ended Second Quarter with $68.6 Million of Cash to Support Growth Plan
$22.0 million backlog at end of Q2 2025
Expected New Orders Across Europe, the Middle East and the United States in 2H 2025 Position OAS for Accelerated Global Expansion into 2026
Conference Call Scheduled for Today at 8:30 a.m. ET
Read More
MMJ BioPharma is taking its fight for FDA approved cannabis medicine directly to DEA Administrator Terry Cole, as President Trump signals openness to marijuana's medical benefits. After seven years of delays, MMJ is ready to launch clinical trials for Huntington's disease and Multiple Sclerosis- if the DEA finally issues its long overdue API Bulk manufacturing registration.
Read More
Genie Healthcare Expands Leadership in Clinical Workforce Solutions with Strategic Investment in Vizzhy's Healthcare IT Platform
Read More
Auctiva has unveiled major platform upgrades aimed at helping eBay sellers grow their businesses, backed by fresh investment under new ownership. The updates include advanced automation, deeper eBay integration, and AI-powered SEO and listing tools to streamline selling. New support for eBay's Negotiation API enables sellers to send personalized offers to interested buyers, boosting conversions and reducing excess inventory. These innovations will be showcased at the 2025 eBay Open, marking the start of a new era of growth and seller-focus.
Read More